Abstract
IS METFORMIN AND VILDAGLIPTIN COMBINATION BETTER THAN METFORMIN AND GLIMEPIRIDE COMBINATION FOR THE MANAGEMENT OF TYPE II DIABETES?

Sapan Shah, Rumana Tokaria, Milan Gajera, Tapan Miyani, Milisha Lal, Rushin Patel Gagan Anand, Parvinder Aulakh, Harsh Chapadia and Abhishek Vadher*

ABSTRACT

Background: In this study, we compared the efficacy and the adverse events of a combination of Metformin-Vildagliptin and Metformin- Glimepiride. Methods: During this study, a total of 248 patients who were diagnosed with type II Diabetes Mellitus were taken. The 118 cases were Metformin combined with Vildagliptin and 126 cases were given Metformin combined with Glimepiride. HbA1c was measured at 3 months after the initiation of the treatment. Results: The reduction of HbA1c in Metformin + Vildagliptin group was 1.23 ±0.43 and in Metformin + Glimepiride group was 1.12±0.68. This showed that the reduction in HbA1c in both the groups was comparable. Hypoglycemia was more in Metformin + Glimepiride group than the Metformin + Vildagliptin group (p value=0.0001).Other adverse events were not statistically significant. Conclusion: The combination of Metformin and Vildagliptin had similar outcomes in reducing HbA1c and similar adverse events when compared to Metformin and Glimepiride, but hypoglycemic events were more common later. Therefore, Metformin and Vildagliptin combination is better than Metformin and Glimepiride combination for the management of type II Diabetes

Keywords: In this study, we compared Metformin + Vildagliptin type II Diabetes.


[Full Text Article]

Login





Forgot Password  |  Register

Indexing

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Tangudu Nagabhusana Rao

Download Article : Click here

News & Updation

  • NEW SEPTEMBER ISSUE PUBLISHED

    SEPTEMBER 2020 Issue has been successfully launched on 1 September 2020.

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT